Oxidative polymorphism of debrisoquine in Parkinson's disease.

Oxidative phenotype and metabolic ratio (MR) of debrisoquine (DBQ) have been determined in 87 patients with Parkinson's disease and in 556 healthy control subjects. Three patients (3.45%) and 34 control subjects (6.12%), having an MR greater than 12.6, were classified as poor metabolisers (PM)...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Benitez, J, Ladero, J M, Jimenez-Jimenez, F J, Martinez, C, Puerto, A M, Valdivielso, M J, Llerena, A, Cobaleda, J, Muñoz, J J
Materialtyp: Artigo
Språk:Inglês
Publicerad: 1990
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC1014165/
https://ncbi.nlm.nih.gov/pubmed/2341841
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk